Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone Augmentation in Schizophrenia
NCT00560937Phase 2Completed
- Sponsor
- Durham VA Health Care System
- Start
- Jun 2005
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pregnenolone in schizophrenia, sponsored by Durham VA Health Care System. Started Jun 2005; status: completed.
02
Drugs
pregnenolone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00560937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00560937.